M L 9 (Levothyroxine 112 mcg (0.112 mg))

Pill imprint M L 9 has been identified as Levothyroxine sodium 112 mcg (0.112 mg).

Levothyroxine is used in the treatment of hashimoto's disease; hypothyroidism, after thyroid removal; underactive thyroid; thyroid suppression test; tsh suppression (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 112 mcg (0.112 mg) is not subject to the Controlled Substances Act.

See also related documents.

Images for M L 9 (Levothyroxine 112 mcg (0.112 mg))

Levothyroxine sodium 112 mcg (0.112 mg) M L 9 Front
Levothyroxine sodium 112 mcg (0.112 mg) M L 9 Back
Levothyroxine sodium 112 mcg (0.112 mg) M L 9
Levothyroxine sodium 112 mcg (0.112 mg) M L 9
Levothyroxine sodium
Imprint:
M
L 9
Strength:
112 mcg (0.112 mg)
Color:
Pink
Size:
9.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-1811
Inactive Ingredients:
butylated hydroxyanisole
silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
povidone
sodium lauryl sulfate
sucrose
D&C Red No. 27
D&C Red No. 30
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-6097 Physicians Total Care Inc (repackager)
23490-6383 Palmetto State Pharmaceuticals Inc (repackager)
43063-0230 PDRX Pharmaceuticals Inc (repackager)
66267-0651 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Hide
(web5)